SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-019297
Filing Date
2021-03-31
Accepted
2021-03-31 17:00:34
Documents
58
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_actiniumpharma.htm 10-K 979437
2 DESCRIPTION OF SECURITIES f10k2020ex4-15_actinium.htm EX-4.15 16425
3 CONSENT OF MARCUM LLP. f10k2020ex23-1_actinium.htm EX-23.1 2069
4 CERTIFICATION f10k2020ex31-1_actinium.htm EX-31.1 8326
5 CERTIFICATION f10k2020ex31-2_actinium.htm EX-31.2 8298
6 CERTIFICATION f10k2020ex32-1_actinium.htm EX-32.1 3452
7 CERTIFICATION f10k2020ex32-2_actinium.htm EX-32.2 3486
  Complete submission text file 0001213900-21-019297.txt   3720012

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE atnm-20201231.xml EX-101.INS 438687
9 XBRL SCHEMA FILE atnm-20201231.xsd EX-101.SCH 48709
10 XBRL CALCULATION FILE atnm-20201231_cal.xml EX-101.CAL 26991
11 XBRL DEFINITION FILE atnm-20201231_def.xml EX-101.DEF 205958
12 XBRL LABEL FILE atnm-20201231_lab.xml EX-101.LAB 408669
13 XBRL PRESENTATION FILE atnm-20201231_pre.xml EX-101.PRE 219214
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 21794315
SIC: 2834 Pharmaceutical Preparations